Stay updated on GeneNews LimitedPress Releases

Sign up to get notified when there's something new on the GeneNews LimitedPress Releases page.
Latest website image capture
Clouds background image

Latest updates to the GeneNews LimitedPress Releases page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Two new press releases were added to the listing (including ARVO 2026 coverage and a campaign with Damon Wayans and diaTribe); two older items were removed, increasing the total results from 499 to 501.
    Difference
    3%
    Check dated 2026-04-30T19:10:27.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The Press Releases results list updates to show new items dated in April 2026, including: “Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68%…” and “Genentech’s Fenebrutinib Significantly Reduced Relapses…” along with an FDA acceptance notice for Gazyva for lupus. Older entries with 2026 January–February dates (including multiple titled research/investment announcements) are removed from the visible results.
    Difference
    3%
    Check dated 2026-04-23T15:30:36.000Z thumbnail image
  4. Check
    58 days ago
    Change Detected
    Summary
    New March 2026 press releases were added (e.g., persevErA study update and ALLEGORY data), and several December 2025 releases were removed.
    Difference
    3%
    Check dated 2026-03-11T17:25:11.000Z thumbnail image
  5. Check
    66 days ago
    Change Detected
    Summary
    The press releases listing now includes a new item: Genentech's Fenebrutinib press release (01 Mar 2026), increasing the total results to 493. An older press release entry (08 Dec 2025) was removed from the listing.
    Difference
    1%
    Check dated 2026-03-04T14:32:14.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Adds two new press releases dated 19 Feb 2026 (FDA NDA for Giredestrant in ESR1-mutated, ER-positive breast cancer and FDA approval of Genentech’s Venclexta Plus Acalabrutinib for untreated CLL) and introduces the Population Health category. Removes two older entries from Nov 2025 related to Giredestrant and Fenebrutinib.
    Difference
    3%
    Check dated 2026-02-25T10:21:46.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added a new press release entry 'Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease' dated 15 Feb 2026, bringing the total results to 490. Removed the older entry 'Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025' dated 03 Nov 2025 from the listing.
    Difference
    0.8%
    Check dated 2026-02-18T07:49:53.000Z thumbnail image

Stay in the know with updates to GeneNews LimitedPress Releases

Enter your email address, and we'll notify you when there's something new on the GeneNews LimitedPress Releases page.